TY  - JOUR
TI  - Everolimus and/or Nivolumab-Associated Cytomegalovirus Colitis in a 
Patient with Metastatic Renal Cell Carcinoma
AB  - Everolimus-associated cytomegalovirus colitis is very rare in cancer patients. We present a case of cytomegalovirus colitis that occurred on using everolimus in a 64-year-old male with metastatic renal cell carcinoma 
who received pazopanib, nivolumab, and everolimus treatments, respectively. Although an increasing number 
of nivolumab-related cytomegalovirus colitis cases are reported recently, its mechanism of development is 
still unknown. Our study highlights that clinicians should remember cytomegalovirus reactivation in the presence of diarrhea or colitis in patients receiving everolimus and/or nivolumab. Further studies are needed 
to elucidate the relationship between immune checkpoint inhibitors and cytomegalovirus reactivation, and 
these will also be a guide to prevent other possible viral infections.
AU  - Sardarova, Konul
AU  - Ismayilov, Rashad
AU  - erman, mustafa
AU  - AKTEPE, Oktay Halit
AU  - Leblebici, Can Berk
DO  - 10.5152/eurasianjmed.2022.20300
PY  - 2022
JO  - Eurasian Journal of Medicine
VL  - 54
IS  - 1
SN  - 1308-8734
SP  - 77
EP  - 79
DB  - TRDizin
UR  - http://search/yayin/detay/524280
ER  -